A clinical trial to study the effect of Collyrium prepared from ayurvedic formulations in patients with pterygium.

A Single Arm Clinical Study of Mudga-Pishtadi Anjana in management of Prastari Arma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014549

Enrollment

Registered

2018-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Prastari Arma, Progressive Pterygium

Interventions

Intervention1: Mudga-pishtadi Anjana: Combination of fine powdered drugs like Mudga-pishta, Sankha Bhasma with Madhu in equal proportion will be applied in the form of Collyrium by sterile Glass rod.

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from symptoms of Prastari Arma and blurring of vision.

Exclusion criteria

Exclusion criteria: Pseudo-pterygium, Inflammed pterygium, or any other ocular or systemic pathologies, and also those patients contraindicated for Anjana therapy.

Design outcomes

Primary

Measure	Time frame
Effect of Mudga-pishtadi Anjana in Prastari-armaTimepoint: 18 months	—

Secondary

Measure	Time frame
Delay in progression of Pterygium.Timepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Nilakshi Shekhar Pradhan

Sumatibhai Shah Ayurved Mahavidyalaya

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026